Extensively Drug-Resistant Shigella flexneri 2a, California, USA, 2022

Emerg Infect Dis. 2023 Jul;29(7):1473-1475. doi: 10.3201/eid2907.230465. Epub 2023 May 19.

Abstract

In Los Angeles, California, USA, persistent, refractory shigellosis was diagnosed in an immunocompetent man who has sex with men. Whole-genome sequencing augmented phenotypic antimicrobial susceptibility testing to comprehensively profile bacterial drug resistance and appropriately guide therapy and clear the infection.

Keywords: California; NGS; Shigella; United States; WGS; XDR; bacteria; extensively drug resistant; next-generation sequencing; whole-genome sequencing.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Drug Resistance, Bacterial
  • Dysentery, Bacillary* / diagnosis
  • Dysentery, Bacillary* / drug therapy
  • Dysentery, Bacillary* / epidemiology
  • Humans
  • Los Angeles
  • Male
  • Microbial Sensitivity Tests
  • Shigella flexneri / genetics
  • Shigella*

Substances

  • Anti-Bacterial Agents